The largest database of trusted experimental protocols

Interferin hts

Manufactured by Polyplus Transfection

INTERFERin-HTS is a cationic polymer-based transfection reagent designed for efficient small interfering RNA (siRNA) delivery in high-throughput screening (HTS) applications. The reagent forms stable complexes with siRNA, facilitating their uptake into target cells. INTERFERin-HTS is optimized for use in 96-well and 384-well plate formats, enabling rapid and reproducible transfection in multiple cell lines.

Automatically generated - may contain errors

6 protocols using interferin hts

1

siRNA Knockdown of TOPK Gene

Check if the same lab product or an alternative is used in the 5 most similar protocols
Reverse-transfection protocol was used (final concentration 20 nM) using Ambion Silencer Select siRNA (LifeTechnologies) INTERFERin-HTS (Polyplus) transfection reagent as previously described (Tiwana et al, 2015 (link)). siTOPK: 5′-GACUAAUGGAUGAAGCUAAtt-3′ siTOPK_2: 5′-CCCUGAGGCUUGUUACAUUtt-3′ siTOPK_3: 5′-GCACUAAUGAAGACCCUAAtt-3′.
+ Open protocol
+ Expand
2

High-throughput Screening of miRNA and siRNA Modulators of HCV Infection

Check if the same lab product or an alternative is used in the 5 most similar protocols
Huh7.5.1 cells were transfected with the miRIDIAN human miRNA mimic library (mIRBase 19) comprising more than 2000 mature miRNAs or 28 ON-TARGETplus smart pool siRNAs (20 nM, Dharmacon) using Interferin HTS (Polyplus) in a 96-well format[8 ]. After 48h, a viability test (Presto Blue, Thermo Scientific) was performed prior to a two-step infection assay[15 (link), 16 (link), 17 (link)]. During part 1 of the protocol, 50 μL of HCV cell culture-derived particles (HCVcc, JcR2a) were incubated with cells during 4h. The inoculum was removed and cells were incubated with 150 μl of medium for 48h. In part 2, supernatants from part 1 cells were transferred onto naïve Huh7.5.1 cells and part 1 cells were lysed to determine luciferase activity[17 (link), 18 (link)]. After 72h, part 2 cells were lysed to determine luciferase activity[17 (link)]. siCD81 (20 nM), antagomiR-122 (100 nM) and siApoE (20 nM) were used as positive controls[17 (link)]. A non-targeting siRNA with no sequence complementarity to any human gene or homology to any human miRNA was used as negative control.
+ Open protocol
+ Expand
3

Optimized siRNA Transfection Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Validation studies used a reverse transfection protocol for siRNA at a final concentration of 20 or 40 nMol/L Ambion Silencer Select siRNA (Life Technologies) and INTERFERin-HTS (Polyplus) transfection reagent concentrations optimized for each cell line. Cells were re-plated for clonogenic assays, immunofluorescence and knockdown confirmation by Western blotting or qRT-PCR at 72-hours post-transfection.
+ Open protocol
+ Expand
4

High-Throughput Mitotic Pathway Screening

Check if the same lab product or an alternative is used in the 5 most similar protocols
Hela cells were grown in clear-bottomed microplates (uClear 384 well microplates, Greiner). Transfection was carried out using Interferin-HTS (Polyplus), according to the manufacturer’s instructions. The siRNA library targeted 840 genes from the Dharmacon Human Druggable siGENOME library, of which 712 were kinase-related, 110 were G-protein coupled receptor-related and 18 were phosphatase-related. After 24 h, cells were accumulated in mitosis for 6 h by addition of 200 nM nocodazole, immunofluorescently stained with mouse anti-H3T3ph (0.1 µg/ml) and rabbit anti-H2BS6ph antibodies (1:1000), followed by fluorophore-conjugated secondary antibodies, and the intensity of staining quantified by High Content Imaging. Experiments were carried out in quadruplicate. The standard score for condition was then calculated, where standard score = (mean staining intensity in presence of siRNA − mean staining intensity for entire plate)/standard deviation of staining intensity for the entire plate; p-values were calculated using one-sample t-test for each siRNA treatment. Approximately 300 cells were measured for each siRNA treatment.
+ Open protocol
+ Expand
5

CRL5 Adaptor Silencing in A549-κB-LUC Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
siRNA sequences targeting CRL5 adaptors were purchased from Horizon Discovery and resuspended in nuclease-free water to 1 μM final concentration. A549-κB-LUC cells were reverse-transfected in triplicate replicates with 30 nM siRNA using Interferin-HTS (Polyplus) and incubated for 72 h. The cells were then stimulated with 1 ng/mL of IL-1β for 6 h and subsequently washed with ice-cold PBS and lysed in Passive Lysis Buffer (PLB; Promega). Luciferase activity was measured in a Clariostar plate reader (BMG Biotech) and data for each sample were normalized to its non-stimulated condition and plotted as mean ± SD over the NTC-transfected control. Data shown are representative of 2 independent screens showing similar results. Cells were also reverse-transfected in identical manner to determine cell viability 72 h post-transfection using CellTiter-Glo (Promega) following manufacturer's recommendations.
+ Open protocol
+ Expand
6

siRNA Transfection for Cell Assays

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were transfected in 6-well plates with siRNA using INTERFERin-HTS (Polyplus) transfection reagent in a reverse transfection procedure. Ambion Silencer Select siRNA (20 nMol/L; Life Technologies) was used for all assays. The sense strand sequences for SRP72 were as follows: SRP72 (1): GGACAAGUGUUAUACCGUU and SRP72 (2): GGCAAUUAGUGACCUACAA. Silencer Select Negative Control No. 1 siRNA was used as negative control. The volume of INTERFERin-HTS ranged from 1 µl to 2 µl per well and the seeding density from 150,000 to 200,000 cells per well, depending on the cell line. Cells were re-plated for colony formation assays, knockdown confirmation, and other downstream assays 72 hours after transfection.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!